MCV is a red blood cell index reported on the complete blood count (CBC). It is a calculated volumetric measure, expressed in femtoliters (fL), derived from the hematocrit and red blood cell count; routine reporting became widespread with the adoption of automated hematology analyzers in clinical labs. Biologically, MCV reflects erythrocyte growth and maturation in the bone marrow as well as membrane and hemoglobin packing. Factors that change cell size include rates of DNA synthesis, availability of iron and B vitamins, recent release of immature cells, and processes that alter cell membrane stability or lifespan.

Lower-than-expected MCV indicates a predominance of smaller red blood cells. This pattern is commonly associated with reduced iron-related availability, inflammatory patterns that alter iron handling, certain inherited hemoglobin traits, or long-standing red cell loss; iron studies, reticulocyte count, and hemoglobin indices help clarify underlying patterns. Higher-than-expected MCV reflects larger average red cells. Associations include altered B12/folate-related nutrient patterns or DNA synthesis, alcohol exposure, liver metabolic changes, some medications that affect cell production, increased young red cell release, or altered thyroid-related activity. Accurate interpretation requires correlation with the rest of the CBC, nutrient panels, liver and thyroid markers, medication history, and clinical context.

MCV is included in the Foundation Zoomer Blood Health domain because it summarizes red cell size, a central feature of oxygen delivery and marrow function. When combined with iron studies, reticulocyte data, nutrient markers, and methylation genetics, MCV helps reveal nutritional, inflammatory, genetic, and metabolic patterns that guide focused follow-up and personalized care planning.